195 related articles for article (PubMed ID: 21673386)
1. Fabrication of a nanocarrier system through self-assembly of plasma protein and its tumor targeting.
Gong G; Zhi F; Wang K; Tang X; Yuan A; Zhao L; Ding D; Hu Y
Nanotechnology; 2011 Jul; 22(29):295603. PubMed ID: 21673386
[TBL] [Abstract][Full Text] [Related]
2. Molecular switch for the assembly of lipophilic drug incorporated plasma protein nanoparticles and in vivo image.
Gong G; Xu Y; Zhou Y; Meng Z; Ren G; Zhao Y; Zhang X; Wu J; Hu Y
Biomacromolecules; 2012 Jan; 13(1):23-8. PubMed ID: 22029860
[TBL] [Abstract][Full Text] [Related]
3. Curcumin-incorporated albumin nanoparticles and its tumor image.
Gong G; Pan Q; Wang K; Wu R; Sun Y; Lu Y
Nanotechnology; 2015 Jan; 26(4):045603. PubMed ID: 25558927
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types.
Bae S; Ma K; Kim TH; Lee ES; Oh KT; Park ES; Lee KC; Youn YS
Biomaterials; 2012 Feb; 33(5):1536-46. PubMed ID: 22118776
[TBL] [Abstract][Full Text] [Related]
5. Investigation of siRNA-loaded polyethylenimine-coated human serum albumin nanoparticle complexes for the treatment of breast cancer.
Abbasi S; Paul A; Prakash S
Cell Biochem Biophys; 2011 Nov; 61(2):277-87. PubMed ID: 21556941
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of obidoxime into human serum albumin nanoparticles: optimisation of preparation parameters for the development of a stable formulation.
Kufleitner J; Worek F; Kreuter J
J Microencapsul; 2010; 27(7):594-601. PubMed ID: 20923399
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
[TBL] [Abstract][Full Text] [Related]
8. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation.
Langer K; Anhorn MG; Steinhauser I; Dreis S; Celebi D; Schrickel N; Faust S; Vogel V
Int J Pharm; 2008 Jan; 347(1-2):109-17. PubMed ID: 17681686
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery.
Guo M; Que C; Wang C; Liu X; Yan H; Liu K
Biomaterials; 2011 Jan; 32(1):185-94. PubMed ID: 21067808
[TBL] [Abstract][Full Text] [Related]
10. A novel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery.
Xu Y; Jin X; Ping Q; Cheng J; Sun M; Cao F; You W; Yuan D
J Control Release; 2010 Sep; 146(3):299-308. PubMed ID: 20580913
[TBL] [Abstract][Full Text] [Related]
11. Drug loading and release on tumor cells using silk fibroin-albumin nanoparticles as carriers.
Subia B; Kundu SC
Nanotechnology; 2013 Jan; 24(3):035103. PubMed ID: 23262833
[TBL] [Abstract][Full Text] [Related]
12. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.
Ulbrich K; Michaelis M; Rothweiler F; Knobloch T; Sithisarn P; Cinatl J; Kreuter J
Int J Pharm; 2011 Mar; 406(1-2):128-34. PubMed ID: 21185364
[TBL] [Abstract][Full Text] [Related]
13. Human Serum Albumin Nanoparticles as a Novel Delivery System for Cabazitaxel.
Zhou G; Jin X; Zhu P; Yao JU; Zhang Y; Teng L; Lee RJ; Zhang X; Hong W
Anticancer Res; 2016 Apr; 36(4):1649-56. PubMed ID: 27069142
[TBL] [Abstract][Full Text] [Related]
14. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
Mandal BB; Kundu SC
Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963
[TBL] [Abstract][Full Text] [Related]
15. Near IR fluorescent polystyrene/albumin core/shell nanoparticles for specific targeting of colonic neoplasms.
Pellach M; Grinberg I; Margel S
Macromol Biosci; 2012 Nov; 12(11):1472-9. PubMed ID: 22976925
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of cyclodextrin complexed hydroxyapatite nanoparticles for preferential albumin adsorption.
Victor SP; Sharma CP
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):221-8. PubMed ID: 21458963
[TBL] [Abstract][Full Text] [Related]
17. Agglomeration and sedimentation of TiO2 nanoparticles in cell culture medium.
Allouni ZE; Cimpan MR; Høl PJ; Skodvin T; Gjerdet NR
Colloids Surf B Biointerfaces; 2009 Jan; 68(1):83-7. PubMed ID: 18980834
[TBL] [Abstract][Full Text] [Related]
18. Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery.
Hu H; Yu J; Li Y; Zhao J; Dong H
J Biomed Mater Res A; 2012 Jan; 100(1):141-8. PubMed ID: 21997951
[TBL] [Abstract][Full Text] [Related]
19. Adsorption of obidoxime onto human serum albumin nanoparticles: drug loading, particle size and drug release.
Kufleitner J; Wagner S; Worek F; von Briesen H; Kreuter J
J Microencapsul; 2010; 27(6):506-13. PubMed ID: 20214419
[TBL] [Abstract][Full Text] [Related]
20. Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate.
Stehle G; Wunder A; Schrenk HH; Hartung G; Heene DL; Sinn H
Anticancer Drugs; 1999 Sep; 10(8):785-90. PubMed ID: 10573211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]